Pharmaceuticals, Biotechnology and Life Sciences
Continued patient enrollment in both the Company-sponsored and NCI-sponsored Phase 3 clinical trials of uproleselan in acute myeloid leukemia (AML)…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Compass Therapeutics, a clinical-stage biotechnology company targeting the human immune synapse with a new generation of monoclonal and…
Respivant also announces 50% enrollment milestone achieved in SCENIC, a Phase 2b Trial of RVT-1601 for the Treatment of Idiopathic…
Cells of 114-year-old converted to young pluripotent stem cells Evidence of reversal of the telomere aging clock in a supercentenarian…
DUBLIN–(BUSINESS WIRE)–The “Biostatistics for the Non-Statistician” conference has been added to ResearchAndMarkets.com’s offering. Statistics is a useful decision-making tool in…
—LabVantage’s Fully Integrated SDMS Provides Unprecedented Ease of Use and Security— —Visit Booth #4432 at Pittcon 2020 to Attend LabVantage…
Conference Call and Webcast Scheduled for 8 a.m. Eastern Time BRISBANE, Calif.–(BUSINESS WIRE)–Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine…
—LIMS Customers Can Now Choose SaaS, Cloud-Hosted, or On-Premise Installations— —Visit Booth #4432 at Pittcon 2020 to Learn More about…
PHOENIX–(BUSINESS WIRE)–Magellan Health, Inc. (NASDAQ: MGLN) today announced financial results for the fourth quarter and full year ended December 31,…
− If approved, the additional treatment modality will provide more options for how patients in Europe receive the gut-selective biologic vedolizumab…